Stem cell infusion trial offers hope for critically ill lung patients
NCT ID NCT03818854
Summary
This study tested whether a single infusion of donor stem cells could help patients with acute respiratory distress syndrome (ARDS), a life-threatening lung condition. Researchers gave 120 critically ill patients either the stem cell treatment or a placebo solution to see if it improved their breathing and recovery. The main goal was to measure changes in lung function and see if patients could spend fewer days on a ventilator.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY DISTRESS SYNDROME, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harborview Medical Center
Seattle, Washington, 98112, United States
-
Memorial Hermann Hospital - Texas Medical Center
Houston, Texas, 77030, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
University of California Davis Medical Center
Sacramento, California, 95817, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.